Association of neoepitopes with disease severity and respiratory hospitalization in patients with IPF

J. Oldham (Sacramento, California, United States of America), J. Todd (Durham, North Carolina, United States of America), M. Neely (Durham, North Carolina, United States of America), H. Mulder (Durham, North Carolina, United States of America), R. Overton (Durham, North Carolina, United States of America), H. Kim (Minneapolis, Minnesota, United States of America), M. Gulati (New Haven, Connecticut, United States of America), T. Leonard (Ridgefield, Connecticut, United States of America), S. Palmer (Durham, North Carolina, United States of America), I. Noth (Charlottesville, Virginia, United States of America), C. Hesslinger (Biberach, Germany)

Source: Virtual Congress 2020 – Promising biomarkers for idiopathic interstitial pneumonia
Session: Promising biomarkers for idiopathic interstitial pneumonia
Session type: Oral Presentation
Number: 5188
Disease area: Interstitial lung diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Oldham (Sacramento, California, United States of America), J. Todd (Durham, North Carolina, United States of America), M. Neely (Durham, North Carolina, United States of America), H. Mulder (Durham, North Carolina, United States of America), R. Overton (Durham, North Carolina, United States of America), H. Kim (Minneapolis, Minnesota, United States of America), M. Gulati (New Haven, Connecticut, United States of America), T. Leonard (Ridgefield, Connecticut, United States of America), S. Palmer (Durham, North Carolina, United States of America), I. Noth (Charlottesville, Virginia, United States of America), C. Hesslinger (Biberach, Germany). Association of neoepitopes with disease severity and respiratory hospitalization in patients with IPF. 5188

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Association between respiratory viruses and exacerbations in COPD patients
Source: Annual Congress 2010 - Genetics and risk factors for asthma and COPD
Year: 2010


Cardiovascular failure versus infectious disease as causes of exacerbation of COPD in a respiratory ICU
Source: Eur Respir J 2006; 28: Suppl. 50, 179s
Year: 2006

Association of systemic inflammation with clinical recovery in patients with acute exacerbation of COPD
Source: Annual Congress 2011 - Phenotyping and monitoring of airway diseases
Year: 2011


Cardiovascular comorbidity in Danish patients with scleroderma-associated interstitial lung disease
Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment
Year: 2017


Association of gastro-esophageal reflux disease symptoms with COPD severity and acute exacerbations of COPD
Source: Annual Congress 2012 - COPD monitoring in stable disease and during exacerbation
Year: 2012


Respiratory comorbidities and risk of mortality in hospitalized patients with idiopathic pulmonary fibrosis.
Source: International Congress 2017 – ILDs: clinical aspects
Year: 2017

Comparison of efficacy of respiratory rehabilitation in patients with COPD and interstitial lung disease
Source: Annual Congress 2011 - Pulmonary rehabilitation: looking at alternative approaches and alternative populations beyond COPD
Year: 2011

Are COPD exacerbations associated with the severity of the disease?
Source: Eur Respir J 2005; 26: Suppl. 49, 300s
Year: 2005

Outcome of patients following hospitalization with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) , with and without cardiovascular risk factors
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016


Exacerbation of respiratory symptoms in COPD patients may not be exacerbations of COPD
Source: Eur Respir J 2013; 41: 993-995
Year: 2013


Psychiatric co-morbidity in patients admitted with acute exacerbation of chronic pulmonary disease and its relationship with symptom severity
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016


In hospitalized COPD exacerbation (COPDE) patients a 30-day readmission is associated with a progressive increased risk of mortality
Source: International Congress 2015 – COPD: interesting notes
Year: 2015

Association between number of steps and mortality in patients with severe chronic obstructive pulmonary disease
Source: International Congress 2017 – Assessing functional outcomes in chronic respiratory disease
Year: 2017

Risk factors for another hospitalization in COPD patients hospitalized for exacerbation
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016


GOLDs definition of COPD in a Norwegian community by self-reported clinical diagnosis of obstructive lung disease and respiratory symptoms
Source: Eur Respir J 2002; 20: Suppl. 38, 122s
Year: 2002

Relationship between pharmacotherapy and severity of disease in patients with COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 73s
Year: 2007

Association of the neutrophil-to-lymphocyte ratio with lung function and exacerbations in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Systemic biomarkers
Year: 2016

Factors affecting in-hospital mortality in patients with chronic obstructive pulmonary disease exacerbation
Source: Annual Congress 2013 –The latest insights in chronic care
Year: 2013

C-reactive protein at discharge, diabetes mellitus and ≥1 prior hospitalization predict early readmission in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2014 – Novel evidence relating to respiratory treatment development
Year: 2014

Does the chronic respiratory disease questionnaire (CRDQ) relate to hospital admission rates in chronic obstructive pulmonary disease (COPD) patients
Source: Eur Respir J 2002; 20: Suppl. 38, 249s
Year: 2002